v3.26.3
Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning Balance at Dec. 31, 2024 $ (78,816) $ 3,029 $ 3,118,865 $ 1,109 $ (3,201,819)
Beginning Balance (in shares) at Dec. 31, 2024   302,960      
Net issuance of common stock associated with stock options and restricted stock units 1,590 $ 10 1,580    
Net issuance of common stock associated with stock options and restricted stock units (in shares)   959      
Stock-based compensation expense 5,385   5,385    
Unrealized gain (loss) on available-for-sale securities 65     65  
Net Income (Loss) 13,158       13,158
Ending Balance at Mar. 31, 2025 (58,618) $ 3,039 3,125,830 1,174 (3,188,661)
Ending Balance (in shares) at Mar. 31, 2025   303,919      
Beginning Balance at Dec. 31, 2024 (78,816) $ 3,029 3,118,865 1,109 (3,201,819)
Beginning Balance (in shares) at Dec. 31, 2024   302,960      
Net Income (Loss) 21,811        
Ending Balance at Sep. 30, 2025 (44,552) $ 3,070 3,132,249 137 (3,180,008)
Ending Balance (in shares) at Sep. 30, 2025   307,027      
Beginning Balance at Mar. 31, 2025 (58,618) $ 3,039 3,125,830 1,174 (3,188,661)
Beginning Balance (in shares) at Mar. 31, 2025   303,919      
Net issuance of common stock associated with stock options and restricted stock units (5,983) $ 20 (6,003)    
Net issuance of common stock associated with stock options and restricted stock units (in shares)   2,040      
Issuance of common stock from market price stock purchase plan 337 $ 1 336    
Issuance of common stock from market price stock purchase plan (in shares)   74      
Issuance of common stock under Employee Stock Purchase Plan 951 $ 3 948    
Issuance of common stock under Employee Stock Purchase Plan (in shares)   299      
Stock-based compensation expense 7,520   7,520    
Unrealized gain (loss) on available-for-sale securities 83     83  
Net Income (Loss) 668       668
Ending Balance at Jun. 30, 2025 (55,042) $ 3,063 3,128,631 1,257 (3,187,993)
Ending Balance (in shares) at Jun. 30, 2025   306,332      
Net issuance of common stock associated with stock options and restricted stock units (743) $ 7 (750)    
Net issuance of common stock associated with stock options and restricted stock units (in shares)   682      
Issuance of common stock from market price stock purchase plan 50   50    
Issuance of common stock from market price stock purchase plan (in shares)   13      
Stock-based compensation expense 4,318   4,318    
Adjustment for impairment loss of available- for-sale investment included in net income (1,269)     (1,269)  
Unrealized gain (loss) on available-for-sale securities 149     149  
Net Income (Loss) 7,985       7,985
Ending Balance at Sep. 30, 2025 (44,552) $ 3,070 3,132,249 137 (3,180,008)
Ending Balance (in shares) at Sep. 30, 2025   307,027      
Beginning Balance at Dec. 31, 2025 (51,022) $ 3,078 3,141,741 115 (3,195,956)
Beginning Balance (in shares) at Dec. 31, 2025   307,833      
Issuance of common stock pursuant to conversion of senior convertible note principal 1,735 $ 6 1,729    
Issuance of common stock pursuant to conversion of senior convertible note principal (in shares)   569      
Net issuance of common stock associated with stock options and restricted stock units 105 $ 4 101    
Net issuance of common stock associated with stock options and restricted stock units (in shares)   402      
Issuance of common stock from market price stock purchase plan 270 $ 1 269    
Issuance of common stock from market price stock purchase plan (in shares)   103      
Stock-based compensation expense 6,455   6,455    
Unrealized gain (loss) on available-for-sale securities (119)     (119)  
Net Income (Loss) (16,619)       (16,619)
Ending Balance at Mar. 31, 2026 (59,195) $ 3,089 3,150,295 (4) (3,212,575)
Ending Balance (in shares) at Mar. 31, 2026   308,907      
Beginning Balance at Dec. 31, 2025 (51,022) $ 3,078 3,141,741 115 (3,195,956)
Beginning Balance (in shares) at Dec. 31, 2025   307,833      
Net Income (Loss) (58,874)        
Ending Balance at Sep. 30, 2026 (37,266) $ 3,216 3,214,437 (88) (3,254,831)
Ending Balance (in shares) at Sep. 30, 2026   321,633      
Beginning Balance at Mar. 31, 2026 (59,195) $ 3,089 3,150,295 (4) (3,212,575)
Beginning Balance (in shares) at Mar. 31, 2026   308,907      
Net issuance of common stock associated with stock options and restricted stock units (823) $ 5 (828)    
Net issuance of common stock associated with stock options and restricted stock units (in shares)   558      
Issuance of common stock from market price stock purchase plan 253 $ 1 252    
Issuance of common stock from market price stock purchase plan (in shares)   62      
Issuance of common stock under Employee Stock Purchase Plan 1,389 $ 4 1,385    
Issuance of common stock under Employee Stock Purchase Plan (in shares)   384      
Stock-based compensation expense 10,226   10,226    
Unrealized gain (loss) on available-for-sale securities (15)     (15)  
Net Income (Loss) (19,032)       (19,032)
Ending Balance at Jun. 30, 2026 (67,197) $ 3,099 3,161,330 (19) (3,231,607)
Ending Balance (in shares) at Jun. 30, 2026   309,911      
Net issuance of common stock associated with stock options and restricted stock units (3,035) $ 13 (3,048)    
Net issuance of common stock associated with stock options and restricted stock units (in shares)   1,281      
Issuance of common stock and pre-funded warrants, net 49,815 $ 104 49,711    
Issuance of common stock and pre-funded warrants, net (in shares)   10,441      
Stock-based compensation expense 6,444   6,444    
Unrealized gain (loss) on available-for-sale securities (69)     (69)  
Net Income (Loss) (23,224)       (23,224)
Ending Balance at Sep. 30, 2026 $ (37,266) $ 3,216 $ 3,214,437 $ (88) $ (3,254,831)
Ending Balance (in shares) at Sep. 30, 2026   321,633